您当前的位置:
首页 >
文章列表页 >
Zhenwutang Ameliorates Diabetic Kidney Disease in Mice with Spleen-kidney Yang Deficiency via Nrf2/HO-1/GPX4 Signaling Pathway
更新时间:2024-07-04
    • Zhenwutang Ameliorates Diabetic Kidney Disease in Mice with Spleen-kidney Yang Deficiency via Nrf2/HO-1/GPX4 Signaling Pathway

    • The latest research found that Zhenwu Decoction can effectively improve the renal function and reduce oxidative damage in the spleen kidney yang deficiency type diabetes nephropathy mice by regulating Nrf2/HO-1/GPX4 signal pathway, providing a new strategy for the treatment of the disease.
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 15, Pages: 29-37(2024)
    • DOI:10.13422/j.cnki.syfjx.20230941    

      CLC: R2-0;R33;R587.1;R692;R289
    • Received:26 May 2023

      Published Online:02 August 2023

      Published:05 August 2024

    移动端阅览

  • ZHAO Zhe,CHEN Guangshun,BAI Min,et al.Zhenwutang Ameliorates Diabetic Kidney Disease in Mice with Spleen-kidney Yang Deficiency via Nrf2/HO-1/GPX4 Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(15):29-37. DOI: 10.13422/j.cnki.syfjx.20230941.

  •  
  •  

0

Views

31

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Zhenzhu Tiaozhi Capsules Reduce Renal Lipid Deposition and Inflammation in Mouse Model of Diabetic Kidney Disease via SCAP-SREBP-1c/NLRP3 Signaling Pathway
Effect of Shenkang Injection on Podocyte Apoptosis and GRP78/CHOP Signaling Pathway in db/db Mice with Diabetic Kidney Disease Based on Endoplasmic Reticulum Stress
Shenqi Dihuang Decoction Improves Renal Function in Mouse Model of Diabetic Kidney Disease by Inhibiting Arachidonic Acid-related Ferroptosis Via ACSL4/LPCAT3/ALOX15 Axis
Mechanism of Modified Shengjiangsan in Improving Diabetic Kidney Disease by Activating Mitochondrial Autophagy Based on PINK1/Parkin Signaling Pathway

Related Author

ZHANG Tao
TAO Jie
ZHANG Yinghui
YANG Yiqi
RONG Xianglu
GUO Jiao
CAI Yanmo
WANG Sitong

Related Institution

Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
The First Affiliated Hospital of Hunan University of Chinese Medicine
Graduate School, Hunan University of Chinese Medicine
0